Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001737287-25-000016)

Filing Details

Accession Number:: 0001737287-25-000016
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-05 16:12:55
Reporting Period:: 2025-02-03

Filing Date:: 2025-02-05
Accepted Time:: 2025-02-05 16:12:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1737287	Allogene Therapeutics Inc.	ALLO	Biological Products, (No Disgnostic Substances) (2836)	823562771

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1851044	Zachary Roberts	210 East Grand Ave South San Francisco CA 94080	Evp Of R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-02-03	18,832	$1.70	643,135	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's electionunder its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.